Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.

Molecular genetic diagnosis is recommended in all patients with NDM. However, if genetic testing results are delayed, sulfonylurea therapy should be considered before such results are received, even in infants with newly diagnosed NDM.